Identification and functional analysis of three novel genetic variants resulting in premature termination codons in three unrelated patients with hereditary antithrombin deficiency

Int J Hematol. 2023 Apr;117(4):523-529. doi: 10.1007/s12185-022-03509-3. Epub 2022 Dec 16.

Abstract

Hereditary antithrombin (AT) deficiency is an autosomal dominant inherited thrombophilia. In three pedigrees of hereditary type I AT deficiency, we identified novel variants c.126delC (p.Lys43Serfs*7), c.165C > G (p.Tyr55*), and c.546delA (p.Lys182Asnfs*102) in the open reading frame encoding AT in each patient. Each of these aberrant variants leads to premature termination of AT protein synthesis. To investigate whether these abnormal variants are involved in the pathogenesis of type I AT deficiency, we analyzed the function of these variants in HEK293 cells. Results of western blot analysis and immunofluorescence microscopy showed that all abnormal variants were expressed intracellularly, but p.Lys43Serfs*7 and p.Tyr55* protein were aggregated in the cells. These three variants were not detected in the spent culture medium, indicating that these novel variants affect protein secretion. In summary, we suggest that these variants in the AT-encoding gene are translated in the cell, but form abnormal proteins that form aggregates and/or inhibit secretion. These results provide insight into novel mechanisms of type I AT deficiency and potential therapies for the condition.

Keywords: Genetic analysis; Hereditary antithrombin deficiency; Recombinant AT protein; Secretory disorder.

MeSH terms

  • Antithrombin III Deficiency* / genetics
  • Antithrombin III* / genetics
  • Antithrombin III* / metabolism
  • Codon, Nonsense
  • HEK293 Cells
  • Humans
  • Thrombophilia* / genetics

Substances

  • Antithrombin III
  • Codon, Nonsense